ARCHIVES

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

This article is from The Cancer Letter archive.

Vol. 38 No. 33 | September 7, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

DCT Board Approves Management Support, Drug Storage Concepts

March 3, 1989

NCI Asks Centers To Limit Increases In Applying For Support Grant Renewals.

October 12, 2001

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014